________
WARNING: Here is the GRAPHIC Australian Government #COVID19 ad to run in Sydney. #COVID19nsw pic.twitter.com/6IXgBy7miw
— Karen Barlow (@KJBar) July 11, 2021
A note on transhumanism and these Covid injections. There is increasing evidence that these Covid injections are the stepping stone into transhumanism. A serious amount of discovery would have to be done to measure the level of transhumanist technology being conducted in Australia at various universities and corporations. This might explain the aggressive communistic tyranny going on in Australia to get Australians Covid vaccinated. Australia itself is an experimental springboard country so this is entirely plausible.
________
Source: The Epoch Times
BY JESSICA MARIE BAUMGARTNER| July 9, 2021
Last week, America's Frontline Doctors (AFLDS) came to speak in Kansas City, Missouri. AFLDS founder Dr. Simone Gold brought her message that COVID-19 is nothing to fear and that there are treatments available. At the start of the pandemic, she was fired after speaking out in support of anti-malaria medication hydroxychloroquine (HCQ).
A pharmacist shows a bottle of the drug hydroxychloroquine in Oakland, Calif., on April 6, 2020. (Ben Margot/AP Photo)
BY JESSICA MARIE BAUMGARTNER| July 9, 2021
Last week, America's Frontline Doctors (AFLDS) came to speak in Kansas City, Missouri. AFLDS founder Dr. Simone Gold brought her message that COVID-19 is nothing to fear and that there are treatments available. At the start of the pandemic, she was fired after speaking out in support of anti-malaria medication hydroxychloroquine (HCQ).
At the time, President Donald Trump was praising the effectiveness of the drug, but shortly after, the FDA revoked emergency use authorization for it. Now, recent studies are confirming that "Low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19."
The Epoch Times interviewed Sarah Abshner, a registered nurse who worked in the field for 8 years but quit this spring and decided to volunteer with AFLDS after what she witnessed. She expressed her passion for the "medical freedom fight" and offered previously unseen materials to support her claims.
She began by introducing herself: "I love being a nurse and had the same concerns as Dr. Gold when we saw what was going on."
Abshner worked through the pandemic up until March 17 of this year. She said she hoped that things would change after the election, but when the big vaccine push came, she knew she couldn't in good conscience stick with the common narrative on COVID-19: "Part of our job is to gather informed consent. With these vaccine trials, they're not offering informed consent. They say it's safe for pregnant women but pregnant women were excluded from the trials."
"We all feel like we saw that things were not right. But physicians are all about reputation and with today's cancel culture. They [the patients] are looking at us and trusting what we're saying. And there was this unspoken line at my job. If I had deviated from the narrative … that's why I left. When we received 'vaccine talking points.'"
Please go to The Epoch Times to continue reading.
________
Source: Mercola
NIAID, Moderna Had COVID Vaccine Candidate in December 2019
Analysis by Dr. Joseph Mercola | July 09, 2021
• Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill on December 12, 2019 — raising significant red flags
• The providers agreed to transfer "mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna" to the university's investigator and was signed by Ralph Baric• Baric pioneered techniques for genetically manipulating coronaviruses, which became a major focus for research at the Wuhan Institute of Virology (WIV)
• Baric worked closely with WIV's Shi Zhengli, Ph.D., on research using genetic engineering to create a "new bat SARS-like virus ... that can jump directly from its bat hosts to humans"• Serious questions need to be answered, including: Were Moderna, NIAID and Baric aware that COVID-19 was circulating in mid-December 2019, or did they have knowledge far before that such a vaccine would soon be in demand?
So much has happened over the past year that it may be hard to remember what life was like pre-COVID. But let's flash back to December 2019, when the idea of social distancing, compulsory masking and lockdowns would have been met with disbelief and outrage by most Americans.
At that time, most were blissfully unaware of the pandemic that would change the world in the next few months. It wasn't until December 31, 2019, that the COVID-19 outbreak was first reported from Wuhan, China,1 and at this point it was only referred to as cases of viral pneumonia, not a novel coronavirus.2 I say "most" because it seems some people may have been aware of something lurking much earlier than it appeared.
In confidential documents3 revealed by the U.K.'s Daily Expose, Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill December 12, 2019 — raising significant red flags. As The Daily Expose reported:4
The confidential disclosure agreement relays a material transfer agreement between the providers — Moderna, NIAID and the National Institutes of Health (NIH) — and the University of North Carolina at Chapel Hill. The providers agreed to transfer "mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna" to the university's investigator.5
Baric, who signed the material transfer agreement to investigate the mRNA coronavirus vaccine candidate before there was a known COVID-19 pandemic, pioneered techniques for genetically manipulating coronaviruses, according to Peter Gøtzsche with the Institute for Scientific Freedom,6 and these became a major focus for WIV.
Baric worked closely with Shi Zhengli, Ph.D., the director of WIV’s Center for Emerging Infectious Diseases, also known as "bat woman," on research using genetic engineering to create a "new bat SARS-like virus ... that can jump directly from its bat hosts to humans." According to Gøtzsche:7
The rest of the story, as the saying goes, is history. December 12, 2019, Amy Petrick, Ph.D., NIAID's technology transfer specialist, signed the agreement, along with Dr. Barney Graham, an investigator for NIAID, whose signature is undated.8 May 12, 2020, just months later, Moderna was granted a fast-track designation for its mRNA-1273 vaccine by the U.S. Food and Drug Administration. According to Moderna’s news release:9
At that time, most were blissfully unaware of the pandemic that would change the world in the next few months. It wasn't until December 31, 2019, that the COVID-19 outbreak was first reported from Wuhan, China,1 and at this point it was only referred to as cases of viral pneumonia, not a novel coronavirus.2 I say "most" because it seems some people may have been aware of something lurking much earlier than it appeared.
In confidential documents3 revealed by the U.K.'s Daily Expose, Moderna, together with the National Institute of Allergy and Infectious Diseases (NIAID), sent mRNA coronavirus vaccine candidates to the University of North Carolina at Chapel Hill December 12, 2019 — raising significant red flags. As The Daily Expose reported:4
"What did Moderna [and NIAID] know that we didn't? In 2019 there was not any singular coronavirus posing a threat to humanity which would warrant a vaccine, and evidence suggests there hasn’t been a singular coronavirus posing a threat to humanity throughout 2020 and 2021 either."COVID-19 Vaccine Candidate Was Released Prior to Pandemic
The confidential disclosure agreement relays a material transfer agreement between the providers — Moderna, NIAID and the National Institutes of Health (NIH) — and the University of North Carolina at Chapel Hill. The providers agreed to transfer "mRNA coronavirus vaccine candidates developed and jointly-owned by NIAID and Moderna" to the university's investigator.5
"The material transfer agreement was signed the December 12th 2019 by Ralph Baric, PhD, at the University of North Carolina at Chapel Hill, and then signed by Jacqueline Quay, Director of Licensing and Innovation Support at the University of North Carolina on December 16th 2019,” Daily Expose noted.At this point, some backstory information is more than relevant. We know with great certainty that researchers at China's Wuhan Institute of Virology (WIV) had access to and were doing gain-of-function research on coronaviruses, and manipulating them to become more infectious and to more easily infect humans. We also know that they collaborated with scientists in the U.S. and received funding from the National Institutes of Health for such research.
Baric, who signed the material transfer agreement to investigate the mRNA coronavirus vaccine candidate before there was a known COVID-19 pandemic, pioneered techniques for genetically manipulating coronaviruses, according to Peter Gøtzsche with the Institute for Scientific Freedom,6 and these became a major focus for WIV.
Baric worked closely with Shi Zhengli, Ph.D., the director of WIV’s Center for Emerging Infectious Diseases, also known as "bat woman," on research using genetic engineering to create a "new bat SARS-like virus ... that can jump directly from its bat hosts to humans." According to Gøtzsche:7
"Their work focused on enhancing the ability of bat viruses to attack humans so as to ‘examine the emergence potential.' In 2015, they created a novel virus by taking the backbone of the SARS virus replacing its spike protein with one from another bat virus known as SHC014-CoV. This manufactured virus was able to infect a lab culture of cells from the human airways.Moderna Gets Emergency Use Approval for COVID Vaccines
They wrote that scientific review panels might deem their research too risky to pursue but argued that it had the potential to prepare for and mitigate future outbreaks. However, the value of gain-of-function studies in preventing the COVID-19 pandemic was negative, as this research highly likely created the pandemic."
The rest of the story, as the saying goes, is history. December 12, 2019, Amy Petrick, Ph.D., NIAID's technology transfer specialist, signed the agreement, along with Dr. Barney Graham, an investigator for NIAID, whose signature is undated.8 May 12, 2020, just months later, Moderna was granted a fast-track designation for its mRNA-1273 vaccine by the U.S. Food and Drug Administration. According to Moderna’s news release:9
"mRNA-1273 is an mRNA vaccine against SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein, which was selected by Moderna in collaboration with investigators from Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), a part of the NIH."December 18, 2020 — about one year after the material transfer agreement was signed — the FDA issued emergency use authorization for Moderna's COVID-19 vaccine for use in individuals 18 years of age and older.10 June 10, 2021, Moderna also filed for emergency use authorization for its COVID-19 shot to be used in U.S. adolescents aged 12 to 17 years.11 Yet, we still have no answers to some glaring questions:12
"It was not until January 9th 2020 that the WHO reported13 Chinese authorities had determined the outbreak was due to a novel coronavirus which later became known as SARS-CoV-2 with the alleged resultant disease dubbed COVID-19. So why was an mRNA coronavirus vaccine candidate developed by Moderna being transferred to the University of North Carolina on December 12th 2019?
… Perhaps Moderna and the National Institute of Allergy and Infectious Diseases would like to explain themselves in a court of law?"
SARS-CoV-2 Appears To Be Uniquely Able to Infect Humans
Nikolai Petrovsky, professor of endocrinology at Flinders University College of Medicine in Adelaide, Australia, is among those who has stated SARS-CoV-2 appears to be optimally designed to infect humans.14
His team sought to identify a way by which animals might have comingled to give rise to SARS-CoV-2, but concluded that it could not be a naturally occurring virus. Petrovsky has previously stated it appears far more likely that the virus was created in a laboratory without the use of genetic engineering, by growing it in different kinds of animal cells.15
Please go to Mercola to read the entire article.
________
More on Moderna:
If readers want more background on Moderna, these Covid injections and the relationship to virus patents, the following discussion provides details. There is also information related to Professor Ralph Baric at the University of North Carolina at Chapel Hill mentioned in the Mercola material above.
Related to the information on the two drugs Remdesivir and Vancomycin mentioned at the beginning of this post:
Related:
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.